United Kingdom (UK) Proton Therapy Market - Reimbursement Policy, Patients Treated at Proton Facility & Forecast - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "United Kingdom (UK) Proton Therapy Market, Reimbursement Policy, Patients Treated at Proton Facility & Forecast" report to their offering.

The UK Proton Therapy Market is expected to grow with a CAGR of 82% in the future. The market is expected to grow 10 times from its current market in 2016. Currently the UK has only one Proton Therapy facility, at Clatterbridge cancer center, and it's a low-energy' machine, only suitable for treating people with rare eye cancers.

Treating more complex cancers requires a high-energy beam, so the NHS covers the cost of sending patients for treatment overseas (in the US or Switzerland) when there's clear evidence that proton beam therapy is the best option. However, this scenario is expected to make a drastic change in the next few years as United Kingdom will have at least 6 Proton Therapy Centers.

Growth Drivers:

  • Technology Advancement
  • Growing Incidence of Cancer Patients in United Kingdom

Challenges:

  • Requires Huge Investment
  • Operations Challenges

Key Companies Covered:

  • IBA
  • Varian Medical Systems
  • Elekta

Key Topics Covered:

1. Executive Summary

2. United Kingdom Proton Therapy Market - Actual & Untapped Market

3. United Kingdom Proton Therapy Patient Number - Actual and Untapped

4. United Kingdom - List of Proton Therapy Centers

5. United Kingdom - Proton Therapy Treated Patients by Centers

6. Proton Therapy - Reimbursement Policies

7. Components of a Standard Proton Therapy Center

8. Global Proton Therapy - Company Analysis (2010-2021)

9. Proton Therapy - Driving Factors

10. Proton Therapy - Challenges

For more information about this report visit http://www.researchandmarkets.com/research/n3zxs2/united_kingdom

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Nuclear Medicine and Radiopharmacology

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Nuclear Medicine and Radiopharmacology